For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
search
Documents
Extraction and LC/MS Analysis of Oligo Therapeutics from Biological Matrices (TN-0048)
This technical note discusses a simple, yet quick and effective solution for isolating and analyzing therapeutic oligonucleotides using Clarity OTX, an extraction kit based on mixed-mode ion-exchange solid phase extraction.
Extraction and LC/MS Analysis of Oligo Therapeutics from Biological Matrices (TN-0048)
This technical note discusses a simple, yet quick and effective solution for isolating and analyzing therapeutic oligonucleotides using Clarity OTX, an extraction kit based on mixed-mode ion-exchange solid phase extraction.
Document Type:
Technical Notes
Target Industries:
Biopharmaceutical Analysis, Clinical Research, Pharmaceutical
Techniques:
HPLC, HPLC Reversed Phase, Oligonucleotide Analysis, Sample Preparation, Solid Phase Extraction
Brands:
Clarity
Separation Modes:
Reversed Phase, Solid Phase Extraction
Phases:
Clarity OTX, Clarity Oligo-MS
save_alt Download
favorite_border
Phenomenex logo
Headquarters
411 Madrid Avenue, Torrance, CA 90501
t: (310) 212-0555 f: (310) 328-7768

OUR PRODUCTS AND SERVICES

Products

Techniques

Industries

OUR COMPANY 

About Phenomenex

Our Humanity

Our People

Blog

Danaher Life Sciences

Stay up to date on the latest from Phenomenex
Iso logo
Terms and Conditions Privacy Statement Quality Policy Terms of Use Trademarks CA Supply Chains Act CA Consumer Privacy Act Cookie Policy Cookie Settings © 2023 Phenomenex Inc. All rights reserved.